Literature DB >> 28189492

HIV Receives a "One Two Knockout Punch".

Conrad Russell Cruz1, Catherine M Bollard2.   

Abstract

Mesh：

Year:  2017        PMID： 28189492      PMCID： PMC5363207          DOI： 10.1016/j.ymthe.2017.02.001

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  13 in total

1.  Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells.

Authors:  Malika Hale; Taylor Mesojednik; Guillermo S Romano Ibarra; Jaya Sahni; Alison Bernard; Karen Sommer; Andrew M Scharenberg; David J Rawlings; Thor A Wagner
Journal:  Mol Ther       Date:  2017-01-28       Impact factor: 11.454

2.  Combining Cell and Gene Therapy in an Effort to Eradicate HIV.

Authors:  Thor A Wagner
Journal:  AIDS Patient Care STDS       Date:  2016-12       Impact factor: 5.078

Review 3.  Gene-modified, cell-based therapies-an overview.

Authors:  Allison B Powell; Kiara Williams; Conrad Russell Y Cruz
Journal:  Cytotherapy       Date:  2016-11       Impact factor: 5.414

4.  Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template.

Authors:  Blythe D Sather; Guillermo S Romano Ibarra; Karen Sommer; Gabrielle Curinga; Malika Hale; Iram F Khan; Swati Singh; Yumei Song; Kamila Gwiazda; Jaya Sahni; Jordan Jarjour; Alexander Astrakhan; Thor A Wagner; Andrew M Scharenberg; David J Rawlings
Journal:  Sci Transl Med       Date:  2015-09-30       Impact factor: 17.956

5.  Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation.

Authors:  Kristina Allers; Gero Hütter; Jörg Hofmann; Christoph Loddenkemper; Kathrin Rieger; Eckhard Thiel; Thomas Schneider
Journal:  Blood       Date:  2010-12-08       Impact factor: 22.113

Review 6.  The democratization of gene editing: Insights from site-specific cleavage and double-strand break repair.

Authors:  Maria Jasin; James E Haber
Journal:  DNA Repair (Amst)       Date:  2016-05-12

7.  In vivo discovery of immunotherapy targets in the tumour microenvironment.

Authors:  Penghui Zhou; Donald R Shaffer; Diana A Alvarez Arias; Yukoh Nakazaki; Wouter Pos; Alexis J Torres; Viviana Cremasco; Stephanie K Dougan; Glenn S Cowley; Kutlu Elpek; Jennifer Brogdon; John Lamb; Shannon J Turley; Hidde L Ploegh; David E Root; J Christopher Love; Glenn Dranoff; Nir Hacohen; Harvey Cantor; Kai W Wucherpfennig
Journal:  Nature       Date:  2014-01-29       Impact factor: 49.962

8.  Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

Authors:  Pablo Tebas; David Stein; Winson W Tang; Ian Frank; Shelley Q Wang; Gary Lee; S Kaye Spratt; Richard T Surosky; Martin A Giedlin; Geoff Nichol; Michael C Holmes; Philip D Gregory; Dale G Ando; Michael Kalos; Ronald G Collman; Gwendolyn Binder-Scholl; Gabriela Plesa; Wei-Ting Hwang; Bruce L Levine; Carl H June
Journal:  N Engl J Med       Date:  2014-03-06       Impact factor: 91.245

9.  Efficient Modification of the CCR5 Locus in Primary Human T Cells With megaTAL Nuclease Establishes HIV-1 Resistance.

Authors:  Guillermo S Romano Ibarra; Biswajit Paul; Blythe D Sather; Patrick M Younan; Karen Sommer; John P Kowalski; Malika Hale; Barry Stoddard; Jordan Jarjour; Alexander Astrakhan; Hans-Peter Kiem; David J Rawlings
Journal:  Mol Ther Nucleic Acids       Date:  2016-08-23       Impact factor: 10.183

10.  Highly efficient homology-driven genome editing in human T cells by combining zinc-finger nuclease mRNA and AAV6 donor delivery.

Authors:  Jianbin Wang; Joshua J DeClercq; Samuel B Hayward; Patrick Wai-Lun Li; David A Shivak; Philip D Gregory; Gary Lee; Michael C Holmes
Journal:  Nucleic Acids Res       Date:  2015-11-02       Impact factor: 16.971
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.